Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 Oct 2;188(20):5487-5498.e16.
doi: 10.1016/j.cell.2025.06.046. Epub 2025 Jul 24.

Mast cells regulate the brain-dura interface and CSF dynamics

Affiliations

Mast cells regulate the brain-dura interface and CSF dynamics

Tornike Mamuladze et al. Cell. .

Abstract

Cerebrospinal fluid (CSF) flow is essential for brain homeostasis, and its disruption is implicated in neurodegenerative and neuroinflammatory diseases. Arachnoid cuff exit (ACE) points, anatomical discontinuities in the arachnoid mater around bridging veins, serve as key sites of CSF-dura exchange. Here, we show that dural mast cells regulate CSF dynamics at ACE points. Upon degranulation, mast cells release histamine, inducing vasodilation of bridging veins and reducing perivascular spaces critical for CSF drainage. During bacterial meningitis, pathogens exploit ACE points to access the brain. However, mast cell activation redirects CSF flow, recruits neutrophils, and limits bacterial invasion. Mice lacking dural mast cells exhibit impaired immune responses and higher brain bacterial loads. These findings reveal dural mast cells as central players in modulating CSF flow and meningeal immunity. Targeting mast cells or their mediators may enhance CNS clearance and defense mechanisms, offering a potential therapeutic avenue for brain infections.

Keywords: ACE points; brain; bridging veins; cerebrospinal fluid; mast cells; meninges; meningitis.

PubMed Disclaimer

Conflict of interest statement

Declaration of interests J.K. is a co-founder of Rho Bio. M.S.D. is a consultant or advisor for Inbios, Moderna, IntegerBio, Merck, GlaxoSmithKline, Bavarian Nordic, and Akagera Medicines. The Diamond laboratory has received unrelated funding support in sponsored research agreements from Emergent BioSolutions, Bavarian Nordic, Moderna, and IntegerBio.

References

    1. Louveau A, Harris TH, and Kipnis J (2015). Revisiting the concept of CNS immune privilege. Trends Immunol 36, 569–577. 10.1016/j.it.2015.08.006. - DOI - PMC - PubMed
    1. Rustenhoven J, and Kipnis J (2022). Brain borders at the central stage of neuroimmunology. Nature 612, 417–429. 10.1038/s41586-022-05474-7. - DOI - PMC - PubMed
    1. Rustenhoven J, Drieu A, Mamuladze T, de Lima KA, Dykstra T, Wall M, Papadopoulos Z, Kanamori M, Salvador AF, Baker W, et al. (2021). Functional characterization of the dural sinuses as a neuroimmune interface. Cell 184, 1000–1016.e27. 10.1016/j.cell.2020.12.040. - DOI - PMC - PubMed
    1. Mazzitelli JA, Smyth LCD, Cross KA, Dykstra T, Sun J, Du S, Mamuladze T, Smirnov I, Rustenhoven J, and Kipnis J (2022). Cerebrospinal fluid regulates skull bone marrow niches via direct access through dural channels. Nat Neurosci 25, 555–560. 10.1038/s41593-022-01029-1. - DOI - PMC - PubMed
    1. Croese T, Castellani G, and Schwartz M (2021). Immune cell compartmentalization for brain surveillance and protection. Nat Immunol 22, 1083–1092. 10.1038/s41590-021-00994-2. - DOI - PubMed

LinkOut - more resources